Verition Fund Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-33,100
Closed -$3.36M 2690
2025
Q4
$3.36M Sell
33,100
-27,300
-45% -$2.19M 0.01% 1169
2025
Q3
$3.3M Buy
60,400
+2,500
+4% +$125K 0.01% 1558
2025
Q2
$3.08M Buy
57,900
+15,300
+36% +$777K 0.01% 1568
2025
Q1
$1.84M Buy
+42,600
New +$2.16M 0.01% 1634

Other funds holding EXAS

Verition Fund Management's EXAS Position: Q1 2026 in Review

Verition Fund Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,234,379 shares — an estimated $125M sold.

Verition Fund Management first reported a position in EXAS in Q2 2018 and held it in 22 quarters. The position peaked at $125M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Verition Fund Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 1,234,379 Exact Sciences shares in Q1 2026, an estimated $125M.
  • Verition Fund Management first reported a position in Exact Sciences in Q2 2018 and held it in 22 quarters.
  • Verition Fund Management's Exact Sciences position peaked at $125M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.